12 Therefore, managing diet involves leveraging the positive aspect of fullness while avoiding choices that exacerbate discomfort due to this slowed digestion
Since GLP-1 medications already slow down digestion, these painkillers may sit in the stomach longer, potentially increasing the risk of acid reflux or gastric irritation
Aging 8 , 14161431 (2016)
This could happen if the treatment and control groups are not comparable- for example if doctors prescribed GLP-1s vs another diabetes medication for systematic reasons such as the health profile of the patient
"One thing medical practitioners can do is think about their own internalised weight stigma." So far, there is no evidence to suggest GLP-1 agonists "target any of the underlying mechanisms" of eating disorders, Dr Trobe said, and in no circumstances should someone with atypical anorexia be prescribed weight-loss medications
Current UK professional guidance emphasises: Patients should inform their surgical team and anaesthetist that they are taking a GLP-1 medication as soon as surgery is planned Healthcare professionals should specifically ask about GLP-1 use during preoperative assessment, as patients may not recognise these medications as relevant to their surgery The decision to continue or pause GLP-1 therapy should be made on an individual risk-based assessment , considering the type of surgery, the specific GLP-1 agent, dose escalation status, presence of gastrointestinal symptoms, and the patient's clinical circumstances Many patients can safely continue GLP-1 medications perioperatively with appropriate precautions, while those at higher risk may benefit from temporary cessation The Summary of Product Characteristics (SmPC) for GLP-1 medications notes the delayed gastric emptying effect, which anaesthetists consider when planning perioperative care
